Plaque Type PsorisisPhase 2NCT07410793
Acupuncture With Chinese Herbal Cream Compare With Acupuncture With Calcipotriol in Plaque Psoriasis.
A Phase 2 study testing Acupuncture, Calcipotriol 0.005% ointment and Chinese herb cream in people with Plaque Type Psorisis, run by Mae Fah Luang University at 1 site in Thailand.
Trial summary
Clinical trial which compares 2 treatment methods (1) Acupunture with a Chinese Herbal Cream and (2) Acupuncture with the standard treatment "calcipotriol" for patients with plaque psoriasis. Read more about this study
- Who is it for?
- Ages 18 to 65 years
- Conditions the study is for
- Plaque Type Psorisis
- What is being tested?
- Acupuncture, Calcipotriol 0.005% ointment and Chinese herb cream
- Type of treatment
- Surgery or procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 28 participants
- Where
- 1 siteThailand
- Study dates
- 9 Feb 2026to 8 Feb 2027
- Phase
- Phase 2
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 65 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Plaque psoriasis on skin, scalp, or nails
- Not receive any psoriasis treatment at least 4 weeks prior to the study
- ≤10% body surface area (BSA), PASI≤10, DLQI≤10
Who cannot join
- Pregnancy and lactation
- Other type of psoriasis i.e. Psoriatic arthritis, Pustular psoriasis, Erythrodermic psoriasis
- Uncontrollable diseases i.e. CVS, liver, kidney, cancer
- Using anticoagulants i.e. Aspirin, Warfarin, Clopidogrel, Dabigatran, Riavaraxaban, Apixaban, Heparin
- Treated with psoriasis biologic agents in the past 6 months
- Needle phobia
- Receiving immunosuppresive agents i.e. systemic corticosteroid, NSAIDs, chemotherapeutic agents
- Participating in other clinical study
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Asst.Prof.Dr.Chakree Chumvisoot Wattanasiri, RPh, PhD contact
Thailand1 site, 1 recruiting
- Recruiting
Mae Fah Luang University
Muang, Chiangrai, 57100
Dr.Sinee Tantasatityanon, TCMD, PhD, +6618092078, sinee.tan@mfu.ac.th
About this study
Official title: Comparative Efficacy of Acupuncture Combined With Chinese Herbal Cream and Acupuncture Combined With Calcipotriol for Plaque Psoriasis.
Clinical trial which compares 2 treatment methods (1) Acupunture with a Chinese Herbal Cream and (2) Acupuncture with the standard treatment "calcipotriol" for patients with plaque psoriasis.
- Conditions
- Plaque Type Psorisis
- Being tested
- Acupuncture, Calcipotriol 0.005% ointment, Chinese herb cream
- Keywords
- plaque psoriasis, acupuncture, chinese herbal cream, calcipotriol
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
AcupunctureProcedure or surgery
Bai-Hui (GV20), Fei-Shu (BL13), Ge-Shu (BL-17), Qu-Chi (LI11), Zu-San-Li (ST36), He-Gu (LI4), Tai-Chong (LR3), San-Yin-Jiao (SP6), Wei-Zhong (BL40)
Calcipotriol 0.005% ointmentDrug
Calcipotriol 0.005% ointment
Chinese herb creamDrug
Main API : Sophora flavescens Ait. (Ku-Shen), Cnidium monnieri (L.) Cuss. (She-Chuang-Zi), Prunus mume (Sieb.) Sieb.et Zucc. (Wu-Mei), Dictamnus dasycarpus Turcz. (Bai-Xian-Pi), Rheum palmatum L. (Da-Huang)
| Study group | Role | What they receive |
|---|---|---|
| Acupucture + Calcipotriol | Active comparator | Participant will receive 1 Acupuncture session per week for 8 weeks. And also receive Calcipotriol cream. Receives: Procedure: Acupuncture; Drug: Calcipotriol 0.005% ointment |
| Acupuncture + Chinese Herbal Cream | Experimental | Participant will receive 1 Acupuncture session per week for 8 weeks. And also receive Chinese Herbal cream. Receives: Procedure: Acupuncture; Drug: Chinese herb cream |
What is being measured
The primary outcome is the main question the study is designed to answer.
Psoriasis Area and Severity Index, PASI score
Measured: 8 weeks
Secondary outcomes (1)
Dermatology Life Quality Index (DLQI)
Measured: 8 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted13 Feb 2026
- Study start9 Feb 2026
- Primary completion8 Feb 2027 (estimated)
- Study completion8 Feb 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Plaque Type PsorisisStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase 2
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 28 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Mae Fah Luang University
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07410793
- Sponsor's protocol ID
- EC 25228-25
- Status last verified
- Feb 2026
- First submitted
- 8 Feb 2026
- Last updated
- 13 Feb 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No